Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Resende

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Sensors (Basel, Switzerland)|December 15, 2018
Beacons and BIM Models for Indoor Guidance and LocationJoao C Ferreira, Ricardo Resende, Stuart Martinho
Heliyon|October 25, 2022
Robotic construction analysis: simulation with virtual realityNuno Pereira da Silva, Sara Eloy, Ricardo Resende
Sensors (Basel, Switzerland)|May 28, 2020
BIM in People2People and Things2People Interactive ProcessBruno Mataloto, João C Ferreira, Ricardo Resende, et al.
Frontiers in Immunology|November 2, 2023
The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicityWojciech Jankowski, Christopher Kidchob, Campbell Bunce, et al.
European Journal of Medicinal Chemistry|September 11, 2018
The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidaseZexin Chen, Patricia Marcé, Ricardo Resende, et al.
Carbohydrate Research|July 21, 2004
Sugar bislactones by one-step oxidative dimerisation with pyridinium chlorochromate versus regioselective oxidation of vicinal diolsAmélia P Rauter, Fátima Piedade, Tânia Almeida, et al.
Science (New York, N.Y.)|February 23, 2013
Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activityJin-Hyo Kim, Ricardo Resende, Tom Wennekes, et al.
Frontiers in Pharmacology|July 5, 2022
Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced <i>in vivo</i> PerformanceNick Evans, Ruslan Grygorash, Paul Williams, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugatesMartin Pabst, William McDowell, Anaïs Manin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Sensors (Basel, Switzerland)|December 15, 2018
Beacons and BIM Models for Indoor Guidance and LocationJoao C Ferreira, Ricardo Resende, Stuart Martinho
Heliyon|October 25, 2022
Robotic construction analysis: simulation with virtual realityNuno Pereira da Silva, Sara Eloy, Ricardo Resende
Sensors (Basel, Switzerland)|May 28, 2020
BIM in People2People and Things2People Interactive ProcessBruno Mataloto, João C Ferreira, Ricardo Resende, et al.
Frontiers in Immunology|November 2, 2023
The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicityWojciech Jankowski, Christopher Kidchob, Campbell Bunce, et al.
European Journal of Medicinal Chemistry|September 11, 2018
The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidaseZexin Chen, Patricia Marcé, Ricardo Resende, et al.
Carbohydrate Research|July 21, 2004
Sugar bislactones by one-step oxidative dimerisation with pyridinium chlorochromate versus regioselective oxidation of vicinal diolsAmélia P Rauter, Fátima Piedade, Tânia Almeida, et al.
Science (New York, N.Y.)|February 23, 2013
Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activityJin-Hyo Kim, Ricardo Resende, Tom Wennekes, et al.
Frontiers in Pharmacology|July 5, 2022
Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced <i>in vivo</i> PerformanceNick Evans, Ruslan Grygorash, Paul Williams, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugatesMartin Pabst, William McDowell, Anaïs Manin, et al.
Pageof 1